Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...

TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Tempus AI has raised an additional $300 million in incremental debt financing from alternative investment manager Ares Management that is intended to support the firm's recent acquisition of Ambry ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI product lines work in concert with one another, creating a pinwheel effect as they generate data, making it more valuable over time. The company launched its 'AI-enabled personal health ...

Tempus is bringing data and AI to healthcare businesses through innovative technology solutions focused on clinical care and research products. With an integrated business model of sequencing patients ...

Tempus AI (NASDAQ: TEM) is a leader in precision medicine and artificial intelligence (AI) in the healthcare sector. Tempus AI’s stock price has seen an increase, with gains of over 160% in the ...

Tempus AI, Inc. Class A (TEM – Research Report) received a Hold rating and price target from William Blair analyst Andrew Brackmann today.